Ibogaine Expert Jonathan Dickinson Explains the Benefits, Potential, and Clinical Research of Ibogaine

Mark is joined by Jonathan Dickinson, global Ibogaine expert, CEO and co-founder of Ambio Life Sciences, and author of Ibogaine and the Bicameral Mind, to discuss the therapeutic potential and clinical applications of Ibogaine. Jonathan shares insights on how Ibogaine interacts with the brain to mitigate opioid withdrawal symptoms, promote neuroplasticity, and assist in treating PTSD and traumatic brain injuries—particularly among military veterans. The two also explore ongoing clinical trials, international safety protocols, and rising legislative and federal interest in expanding research into psychedelic-assisted therapies.